Matthew Reilley

7PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Family and household studiesMolecular targetsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Andrew L Coveler, Matthew J Reilley, Mark Zalupski

|Feb 15, 2024
Associations between income and survival in cholangiocarcinoma: A comprehensive subtype-based analysis.

Calvin X Geng, Anuragh R Gudur, Jagannath Kadiyala

|Dec 01, 2023
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.

Matthew H G Katz, Gina R Petroni, Todd Bauer

|Sep 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.

Lestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino

|Sep 15, 2023
Complete response to immunotherapy in a patient with high-risk stage III colorectal cancer after ctDNA-guided detection of early adjuvant treatment failure.

Nicholas Lucchesi, Jenna M Ally, Matthew J Reilley

|Aug 30, 2023
Associations between context and affect within the daily lives of cancer caregivers.

Katharine E Daniel, Jillian V Glazer, Tri Le

Pageof 2

Frequent Collaborators

2 joint publications

Matthew H G Katz

2 joint publications

Stephanie K Dougan

2 joint publications

Jonathan Andrew Nowak

2 joint publications

Craig L Slingluff